Cumberland reports positive cancer trial results for ifetroban drug
Go back to Cumberland reports positive cancer trial results for ifetroban drug| Cumberland Pharmaceuticals, Inc. (NASDAQ: CPIX) | Delayed: 5.83 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.83 | 52 Week High | $5.95 | |||
| Open | $5.83 | 52 Week Low | $4.20 | |||
| Day High | $5.83 | P/E | 97.17 | |||
| Day Low | $5.83 | EPS | $0.06 | |||
| Volume | 5 | |||||
